Innovative Pioneer of Sustainable Medical Solutions
NexThera Co., Ltd. is a biotech venture company leveraging its recombinant protein-based platform technology -- including peptides -- to develop a novel therapeutic and delivery platform for wet age-related macular degeneration (wAMD), biobetter development, and antibody-based therapeutic for thrombocytopenia. By collaborating and forging partnerships with leading universities, research institutions, hospitals, and other key opinion leaders in the industry, NexThera is dedicated to developing novel therapies, biobetters, and platforms that contribute to human health. NexThera strives to grow as a socially responsible biotech company by contributing to a thriving local bio-ecosystem, supporting job creation, and creating an environment where young and talented scientists can fully devote themselves to cutting-edge research.
We will create a differentiated bio company to fulfill the vision and values of NexThera.
CEO Message
NexThera Co., Ltd. is a new bio venture company founded in 2020. The company's key members and researchers have cultivated differentiated technological prowess and research capabilities through accumulated research activities at their affiliated universities and national research grant.

Through these efforts, the company has developed continuous and scalable pipeline technologies. In particular, NexThera’s eye drop therapeutics and delivery platform technology for age-related macular degeneration (wAMD) and diabetic retinopathy, as well as recombinant protein-based biobetter development platform technology, demonstrate strong growth potential and draw attention from leading domestic and foreign institutional investors.

Through the development and launch of innovative and sustainable medical solutions, NexThera strives to play a leading role in driving the local bio-ecosystem.
We will grow as a socially responsible company,
contributing to a thriving local bio-ecosystem
and healthy job environment.
NexThera, Co., Ltd.
CEO, SaeGwang Park, M.D./Ph.D.
We will grow as a socially responsible company,
contributing to a thriving local bio-ecosystem
and healthy job environment.
NexThera, Co., Ltd.
CEO, SaeGwang Park, M.D./Ph.D.
To promote human health and welfare, NexThera will continue to provide innovative and sustainable medical solutions that people can trust and use, and grow by building the best therapeutics and platforms. NexThera will establish and implement common goals and principles, and adhere to the following to achieve its vision.
Act with integrity and stick to high ethical standards.
Realize continuous development and growth.
Develop innovative therapeutics and platforms to meet future unmet needs.
Practice industrial safety, environmental protection, and social contribution at all business sites.
Achieve high shareholder returns.
NexThera's identity is based on high ethical standards and a firm belief in transparency. The company executes business strategies based on a firm sense of ethics that is not compromised under any circumstances.
Commitment to Human Health
NexThera conducts business to promote human health and welfare.
Respect for Employees
NexThera provides its employees with a safe, healthy, and pleasant working environment. The company respects the diversity of its people, encourages teamwork, and provides appropriate rewards for performance. In addition, the company supports employee growth by creating an environment where continuous learning and expression of diverse opinions are respected.
Awareness of social concerns and needs
NexThera recognizes its responsibility to promote human health and welfare in the areas in which we operate. To this end, the company operates using the right environmental, health, safety, and therapeutic management practices. NexThera is also actively involved in communication, government policy, and community outreach.
Responsibility to Shareholders
NexThera is a company that does its best in corporate responsibility and profit generation for shareholders.
02. 17.
Company established in Inje University (Gimhae, South Gyeongsang Province, South Korea)
05. 11.
Signs MOU with DongKook Pharmaceutical for joint development of eye drop therapeutic for wet age-related macular degeneration (AMD)
06. 01.
Receives the “Startup Leap Package”, sponsored by the Ministry of SMEs and Startups (110,000,000 KRW)
08. 14.
Dr. Jee-Yeong Jeong appointed as CTO
11. 02.
Receives the “INNOPOLIS Grants for Public Technology Commercialization” sponsored by the Ministry of Science and ICT (165,000,000 KRW)
11. 23.
BNK VC joins Seed B round
12. 01.
Mr. Stephan Jeong appointed as COO
12. 17.
Becomes a certified venture company
12. 28.
Platinum Technology Investment joins Seed B round
02. 01.
Opens Corporate Affiliated Research Institute, the NT R&D Center
03. 02.
Relocates Headquarters (Haeundae-gu, Busan, South Korea)
03. 11.
Opens Gimhae branch
03. 31.
Selected for TIPS Program (Accelerator Investment-Driven Tech Incubator Program for Startup)
04. 06.
Selected for 13th Technology Start-up incubation (Busan Economic Promotion Agency)
04. 13.
Selected for Frontier Venture by TECH Valley (Korea Technology Finance Corporation)
KB Investment & BNK VC joins Series A round
Korea Technology Finance Corporation(Kibo) joins Series A round
01. 08.
DAOL Investment (ex. KTB Networks)/KB Securities, Platinum Technology Investment joined Series A round
03. 02.
HQ, R&D center Relocation (4F, Busan Office Bldg. Busan, Korea)
11. 01.
Selected as a Baby Unicorn Company by the Ministry of SMEs and Startups
Ethics Management
Ethics Charter
NexThera is a proud contributor to human welfare by effectively addressing projects of unmet medical needs, that help grow and advance the biopharmaceutical industry.
We strive to be a global biotech venture that is respected and trusted by the global market through ethics and compliance practices of the highest standard.
We will fulfill our vision through creative thinking and adventurous mindset, and we will always conduct business based on fair and honest attitudes, striving to foster a clean environment with no corruption.
We will dedicate ourselves to research & development with the goal of advancing human health and the biopharmaceutical industry in mind.
We will achieve shared prosperity by complying with domestic and international laws and regulations, and establishing a cooperative working relationship with all stakeholders.
We will treat each employee with respect and fairness. We will not discriminate against any employee, ensure that we provide them with equal opportunities and evaluations, and contribute to improving their health and quality of life.
We will actively participate in community activities and constantly work towards value creation to contribute to the development of the country and society.
Ethics and Compliance Practices in Observance of Laws & Principles
Achieve 4th Industrial Revolution Through Internalization
Demonstrate Strong R&D Capabilities
Establish NexThera as a high integrity company that promotes clean, transparent management
Become an example for others on honest and ethical management